Biohaven Pharmaceutical Holding Company Ltd
Most Recent
Insys Therapeutics: Recommendations and Market Capitalization
Wall Street analysts estimate that INSY stock could decrease ~3% over the next 12 months. That show a 12-month target price of $9.60.